Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Arabidopsis thaliana
(NCBI:txid3702)
|
See:
PubMed
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
micronutrient
Any nutrient required in small quantities by organisms throughout their life in order to orchestrate a range of physiological functions.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
EC 1.14.13.39 (nitric oxide synthase) inhibitor
An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of nitric oxide synthase (EC 1.14.13.39).
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Daphnia magna metabolite
A Daphnia metabolite produced by the species Daphnia magna.
(via citrulline )
hapten
Any substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
(via citrulline )
|
|
nutraceutical
A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
protective agent
Synthetic or natural substance which is given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.
|
|
(2S)-2-amino-5-(carbamoylamino)pentanoic acid
|
L-citrulline
|
N5-carbamoyl-L-ornithine
|
(S)-2-Amino-5-ureidopentanoic acid
|
HMDB
|
2-Amino-5-ureidovaleric acid
|
KEGG COMPOUND
|
α-amino-δ-ureidovaleric acid
|
ChemIDplus
|
Cit
|
ChemIDplus
|
CITRULLINE
|
PDBeChem
|
Citrulline
|
KEGG COMPOUND
|
δ-ureidonorvaline
|
ChemIDplus
|
L-2-Amino-5-ureidovaleric acid
|
HMDB
|
L-Citrulline
|
KEGG COMPOUND
|
N5-(aminocarbonyl)-L-ornithine
|
ChemIDplus
|
N5-(Aminocarbonyl)ornithine
|
DrugBank
|
N5-carbamoylornithine
|
DrugBank
|
Nδ-carbamylornithine
|
ChemIDplus
|
1725416
|
Reaxys Registry Number
|
Reaxys
|
372-75-8
|
CAS Registry Number
|
ChemIDplus
|
6055157
|
Beilstein Registry Number
|
Beilstein
|
774677
|
Gmelin Registry Number
|
Gmelin
|